Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials

BACKGROUND: High on-treatment platelet reactivity (HPR) represents a strong risk factor for thrombotic events after PCI. We aim to evaluate the efficacy and safety of individualizing intensified dual antiplatelet therapy (DAPT) in PCI-treated patients with HPR based on platelet function testing (PFT...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yijiang, Wang, Yanwei, Wu, Yutao, Huang, Chaoyang, Yan, Hui, Zhu, Weiguo, Xu, Weiwei, Zhang, Li, Zhu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472866/
https://www.ncbi.nlm.nih.gov/pubmed/28619104
http://dx.doi.org/10.1186/s12872-017-0582-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472866/
https://www.ncbi.nlm.nih.gov/pubmed/28619104
http://dx.doi.org/10.1186/s12872-017-0582-6

Ejemplares similares